Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nuclear ribonucleoprotein polypeptide C pseudogene 13 (SNRPCP13) is a pseudogene of the SNRPC gene in humans. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional; they often derive from protein-coding genes through duplication or mutation, but they do not encode functional proteins. The SNRPC gene encodes a specific component of the U1 small nuclear ribonucleoprotein (snRNP) particle, which is essential for pre-mRNA splicing, but the SNRPCP13 pseudogene does not appear to have coding capacity or therapeutic relevance. There is no evidence that SNRPCP13 is a therapeutic target, is involved in disease, or interacts with drugs. The only available information is its locus and classification as a pseudogene; no biological function or disease association is established for this pseudogene. SNRPCP13 is a pseudogene, not a protein, receptor, enzyme, transporter, or validated drug target. No reported biological function or disease association is linked specifically to SNRPCP13; it is distinguished from functional SNRPC protein and pseudogenes like SNRPFP1, which have described regulatory non-coding RNA activity in tumors. No aliases beyond its systematic name; no entries in drug-target or disease association databases; no biomarker or mechanism of action data. The query is "incorrect" in the context of therapeutic targeting as SNRPCP13 is a pseudogene, not a functional protein or targetable molecule. There are no data suggesting it is relevant as a receptor, enzyme, or drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide C pseudogene 13 (SNRPCP13).